2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92606°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¾È·¦, ´Ù¾çÇÑ ÁÖÁ¦·Î À§ÀåÇØ À¯Æ÷ ÁßÀÎ ÇÇ½Ì ¸ÞÀÏ ÁÖÀÇ ´çºÎ (2024-06-22)
New Research Shows Consumers Pay the Price of Policy Abuse E... (2024-10-18)
»ùÇ¥, 2024³â ¼³ ¸ÂÀÌ ±âȹÀü¡¦ ÃÖ´ë 55% ÇÒÀÎ (2024-02-07)
Neu-REFIX Beta glucan receives rare pediatric disease and or... (2024-09-30)
¡®¾Æ³Ý»ç ¼±»þÀÎ ÇÁ·ÎÁ§Æ®¡¯ ÅëÇØ ¾î¸°ÀÌÀÇ À£ºù Áö¿ø (2024-05-17)
Å¥¸®¾ðÆ® ¾Æµå¸¯¼¼Æ¼´Õ, Èñ±Í Ç÷¾×¾Ï ÀÓ»ó IND ½ÂÀÎ (2024-06-27)
Cascale Introduces New Membership Engagement Model, Elevates... (2024-11-10)
¡®³» ¹æ¿¡¼­ ¸¸³ª´Â ±æ À§ÀÇ Àι®ÇС¯ 20°³ °­ÀÇ ÄÜÅÙÃ÷ ¹èÆ÷ (2024-01-25)
Z¼¼´ë°¡ °¡Àå Ãë¾÷ÇÏ°í ½ÍÀº ´ë±â¾÷ 1À§ '»ï¼ºÀüÀÚ' (2023-08-24)
ÀüÅë°ø¿¬¿¹¼ú ¾ð·ÐÈ«º¸ Áö¿ø Âü¿© ¿¹¼úÀÎ ¸ðÁý (2024-03-24)
¿ì¸® µ¿³× µµ½¼Æ®°¡ µÇ¾îº¸´Â Áú°í·¡ºñ (2023-10-22)
³²ºÏû¼Ò³âÁß¾Ó¿¬¸Í, û¼Ò³â ÅëÀϹéÀÏÀå Àü±¹´ëȸ °ø°í (2024-05-22)
¹Ì·¡±³À°, ÀÌÁ¦ XR ½Ã´ë¡¦ º£½ºÆ®ÅØ, ¡®Áö½ºÆäÀ̽º¡¯ °ø±Þ (2024-04-16)
AIDOLTV ¡®µ¿¹°°ú ÇÔ²² ÆÝ! ¿µ»ó ÄÜÅ×½ºÆ®¡¯ ÁøÇà (2024-01-12)
2024 ½ÅÁø±¹¾Ç½ÇÇ蹫´ë ¡®Ã¢ÀÛ ¹× ÀüÅë ½ÅÁø¿¹¼ú°¡¡¯ ¸ðÁý (2024-03-29)
AnyQuest Improves Citizen Developer Productivity by Launchin... (2023-12-07)
Á¦ÀÏÀü±â°ø¾÷, ¡®ÇнÀÁ¶Á÷È­ ¿ì¼ö±â¾÷ °æÁø´ëȸ¡¯ ´ë»ó (2023-09-26)
NSF Certifies Microfilter as the World¡¯s First Client for N... (2023-12-12)
APR Shows Record High Q1 Performance with KRW 122.2 Billion ... (2023-05-18)
¿ì¸®±ÝÀ¶¿¡ÇÁ¾Ø¾ÆÀÌ, NPL ÅõÀÚ ½Çź È®º¸ (2024-06-01)
K-µå·Ð ±â¼úÀÇ Áß¾Ó¾Æ½Ã¾Æ ½ÃÀå ÆÇ·Î °³Ã´ À§ÇÑ ºñ»ó (2024-05-14)
ÇÑÁ¤ÆÇ ¡®Á¶´Ï¿öÄ¿ ºí·¢ ¼Î¸® ÇǴϽ¬¡¯ ÀçÃâ½Ã (2023-12-17)
¿ì¸®´Â À§´ëÇÑ ¼¼ÀÏÁî¸ÇÀÌ µÉ ¼ö ÀÖ´Ù (2016-07-06)
64Audio, Ƽ¾Æ ±â¼úÀ» Àû¿ëÇÑ ¡®Tia Fourte, U18 Tzar¡¯ (2017-05-28)
1879MG, ¸â¹ö½Ê ȸ¿ø¸ðÁý¡¦ ºñÁî´Ï½º ³×Æ®¿öÅ© °­È­ (2024-03-03)
       [ÀÌÀü][1]....[706][707][708][709][710][711][712][713][714]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..